Novel Approach to Hormonal Health
Overview of innovation
The technology integrates melatonin with bio-identical estrogen to counteract the pro tumorigenic effects associated with estrogen. The research conducted demonstrated that combining melatonin with estrogen diminishes estrogen’s proliferative impact on breast cancer cells and attenuates their migratory capabilities. Therefore, the approach holds promise for enhancing melatonin levels while potentially reducing cancer cell proliferation.
Innovation Opportunity Type
Investment
Licensing
Partnership
Industry
Manufacturing
Manufacture of pharmaceuticals, medicinal chemical and botanical products
Professional, scientific and technical activities
Scientific research and development
Human health and social work activities
Human health activities
Technology Readiness Level
TRL 3 – Proof of concept created
Website link
https://app.in-part.com/university-dashboard/technologies/20107